Consolidation beat goes on
The consolidation rage continues. This time it is happening in the pharmaceutical industry.
Just when will consolidation end? Are there more rounds to go?
Germany’s Merck made a huge move to pick up Schering today. Merck is looking at paying $17.4 billion for its fellow German drug maker. Since Schering feels the offer is too low, they rejected the bid, but Merck is moving forward with a hostile takeover. Other bidders could jump in at any time.
Meanwhile, in a much friendlier scenario, Corona, Calif.-based Watson Pharmaceuticals Inc., a maker of generic versions of Valium, Percocet and other drugs, said it will pay $1.9 billion to acquire rival drug manufacturer Andrx Corp. of Plantation, Fla.
You can pretty much guarantee there will be more deals breaking in the industry in the coming months. It seems like it is just a matter of time.
What companies are next? Talk to me.
Just when will consolidation end? Are there more rounds to go?
Germany’s Merck made a huge move to pick up Schering today. Merck is looking at paying $17.4 billion for its fellow German drug maker. Since Schering feels the offer is too low, they rejected the bid, but Merck is moving forward with a hostile takeover. Other bidders could jump in at any time.
Meanwhile, in a much friendlier scenario, Corona, Calif.-based Watson Pharmaceuticals Inc., a maker of generic versions of Valium, Percocet and other drugs, said it will pay $1.9 billion to acquire rival drug manufacturer Andrx Corp. of Plantation, Fla.
You can pretty much guarantee there will be more deals breaking in the industry in the coming months. It seems like it is just a matter of time.
What companies are next? Talk to me.
0 Comments:
Post a Comment
<< Home